Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Neither peptide is FDA-approved for human therapeutic use
A Narrative Review of BPC-157 for Musculoskeletal Healing Evaluated BPC-157's molecular mechanisms and therapeutic potential for musculoskeletal injuries including tendons, ligaments, and cartilage, noting promising preclinical results and discussing the safety profile relevant to clinical translation (Curr Rev Musculoskelet Med, 2025)
Challenges with peptide-based therapies for back pain To probe whether this peptide might be used as a drug therapy to delay or prevent degeneration, the team treated mice with the peptide for four consecutive weeks
Why people switch The most common reasons include weight loss plateaus, inadequate response at maximum dose, side effect intolerance, cost or insurance changes, and desire for greater efficacy
It can also lead to adverse health outcomes in people struggling with diabetes and kidney disease
By promoting the regrowth of blood vessels, BPC-157 ensures the surgical site receives better circulation, which is necessary for bone regeneration and healing
